MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
Go back to MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program| Gilead Sciences (NASDAQ: GILD) | Delayed: 124.15 +0.39 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.76 | 52 Week High | $108.63 | |||
| Open | $124.30 | 52 Week Low | $71.39 | |||
| Day High | $125.17 | P/E | 68.59 | |||
| Day Low | $123.00 | EPS | $1.81 | |||
| Volume | 4,272,694 | |||||
| MACROGENICS (NASDAQ: MGNX) | Delayed: 4.47 +0.34 (8.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.13 | 52 Week High | $36.11 | |||
| Open | $4.01 | 52 Week Low | $14.84 | |||
| Day High | $4.47 | P/E | 11.46 | |||
| Day Low | $4.00 | EPS | $0.39 | |||
| Volume | 1,473,381 | |||||

